Xanadu Quantum Technologies Ltd (XNDU) Form 424B3 — Oct 19, 2026
Xanadu Quantum Technologies (NASDAQ/TSX: XNDU) filed Supplement No. 3 to its June 2026 F-1 prospectus, incorporating its October 19, 2026 Form 6-K and fiscal 2025 Form 20-F. The supplement is administrative but carries the embedded 6-K news. The key disclosure is provisional approval for up to USD $10 million in additional funding under DARPA's Quantum Benchmarking Initiative, a one-year contract extension that builds on Xanadu's Stage B work.
Key figures
- Contract term
- one-year extension
- Last tsx price
- C$4.29
- Darpa funding usd
- $10 million
- Last nasdaq price
- $3.04
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.